Ephraim Vidal

Title: Ephraim Vidal: Innovator in Pharmaceutical Chemistry

Introduction

Ephraim Vidal is a notable inventor based in Summit, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for therapeutic use.

Latest Patents

Ephraim Vidal holds a patent for a compound titled "Dimethylaminoethanol salt of a GLP-1 receptor modulator - Crystalline 2-hydroxy-N,N-dimethylethanaminium 1-(2-(5-(tert-butyl)-thiophene-2-carboxamido)-3-(4-(5-(4'-ethyl-[1,1′-bi(cyclohexan)]-3-en-4-yl)pyrimidin-2-yl)phenyl)propanoyl)azetidine-3-carboxylate salt, and methods related to synthesis and therapeutic use of the same." This patent showcases his expertise in creating complex chemical structures with potential medical applications.

Career Highlights

Ephraim Vidal is currently employed at Receptos, Inc., where he continues to advance his research and development efforts. His work focuses on innovative solutions that address critical health challenges.

Collaborations

Ephraim has collaborated with esteemed colleagues such as Roger Bakale and Philip Turnbull. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Ephraim Vidal's contributions to pharmaceutical chemistry and his innovative patent highlight his role as a key figure in the field. His ongoing work at Receptos, Inc. continues to pave the way for advancements in therapeutic solutions.